When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Results from a Phase 3 clinical trial, PARTNER 3, evaluating Edwards Lifesciences' (EW+9.1%) SAPIEN 3 mitral valve in patients with severe symptomatic aortic stenosis (narrowing of the aorta) showed its superiority to surgery. The data were presented at the American College of Cardiology Annual Scientific Sessions in New Orleans.
More news on: Edwards Lifesciences Corporation, Healthcare stocks news, Stocks on the move,